Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review

Magdalena Sokulska1, Marta Kicia, Maria Wesołowska

  • 1Department of Biology and Medical Parasitology, Wrocław Medical University, ul. Mikulicza-Radeckiego 9, 50-367, Wrocław, Poland.

Parasitology Research
|August 19, 2015
PubMed

Insights

Pneumocystis pneumonia remains a threat, especially in immunosuppressed HIV-negative patients. Early detection and differentiating colonization from infection are crucial for managing this opportunistic fungal disease.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Hosts

Background:

  • Pneumocystis pneumonia (PCP) is an opportunistic infection caused by Pneumocystis jirovecii.
  • While ART and prophylaxis reduced PCP in HIV patients, it remains a significant threat in immunosuppressed HIV-negative individuals (transplant recipients, cancer patients).
  • Asymptomatic colonization occurs in immunocompetent individuals, with potential links to sudden unexpected infant death syndrome.

Purpose of the Study:

  • To highlight the critical issue of pneumocystosis in immunosuppressed HIV-negative patients.
  • To emphasize the importance of understanding colonization versus infection.
  • To discuss emerging drug-resistant strains and their epidemiological impact.

Main Methods:

  • Review of existing literature on Pneumocystis jirovecii epidemiology and clinical manifestations.
  • Discussion of diagnostic challenges in distinguishing colonization from active disease.
  • Summary of sensitive and specific detection methods for Pneumocystis invasion.

Main Results:

  • Pneumocystis pneumonia presents with rapid onset and high mortality in at-risk immunosuppressed populations.
  • Genetic diversity of Pneumocystis jirovecii contributes to varying epidemiological profiles and potential drug resistance.
  • Accurate diagnostic methods are essential for effective patient management.

Conclusions:

  • Pneumocystis pneumonia continues to be a major cause of mortality in specific immunosuppressed patient groups.
  • Distinguishing colonization from invasive disease is critical for appropriate treatment and prognosis.
  • Ongoing research into diagnostic methods and emerging strains is vital for combating this opportunistic infection.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
47
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K